World
Hadi Matar convicted in terrorism trial over Salman Rushdie stabbing

A man was convicted on Wednesday of federal terrorism charges in the 2022 stabbing of Salman Rushdie, the author who has faced a decades-old death threat over his novel The Satanic Verses.
A jury found Hadi Matar guilty of all the charges against him, including engaging in an act of transnational terrorism.
A message seeking comment was sent to Matar’s lawyers.
Matar, 28, is already serving a 25-year New York state prison sentence on an attempted murder conviction in the August 2022 attack on an amphitheatre stage. The federal conviction carries a potential life sentence.
Rushdie, who was about to speak on writers’ safety, was slashed 15 times in front of a stunned audience. He was gravely wounded and lost the sight in his right eye.
Prosecutors asserted that Matar was motivated by the late Iranian Supreme Leader Ayatollah Ruhollah Khomeini’s 1989 call for Rushdie’s death because of The Satanic Verses. Defence lawyer Nathaniel Barone countered that the government had no proof of what was in Matar’s head.

Politics19 hours agoIs Tinubu Going For Boxing Or 100 Metres? – APC Chairman, Yilwatda Slams Peter Obi Over ‘Tired’ Remark
News24 hours agoEXCLUSIVE: Police Indict Unity Bank Cooperative Officials in ₦85 Million Fraud Investigation – Secrets Reporters Nigeria
Politics13 hours agoTaraba Lawmaker Calls On State Government To Accord Priority, Funding To Hepatitis Treatment As HIV/AIDS
Viral17 hours ago“My sister, family turned against me because I refused to care for the child I birthed” — Lady reveals
Entertainment6 hours ago“I opened an account”- Nigerian lady who relocated to Canada displays account balance, amount sparks buzz
Viral16 hours agoProfessional Indictment: Lawyer Ejiofor’s Dubious Mix of Civil and Criminal Procedure Keeps Kanu in Chains
Entertainment10 hours agoOdogwu Asaba: “She is hungry”- Late Favour’s twin explains why she brought bread, sardine to her grave
Metro8 hours ago“FG Unveils Seven Locally Developed Herbal Products” — NNMDA Targets Cancer, Hepatitis B, Hypertension























